Cargando…
Optimized Administration of the M(4) PAM VU0467154 Demonstrates Broad Efficacy, but Limited Effective Concentrations in Mecp2(+/–) Mice
[Image: see text] Hypofunction of cholinergic circuits and diminished cholinergic tone have been associated with the neurodevelopmental disorder Rett syndrome (RTT). Specifically, deletion of Mecp2 in cholinergic neurons evokes the same social and cognitive phenotypes in mice seen with global Mecp2...
Autores principales: | Cikowski, Jakub, Holt, Calista, Arthur, Bright, Smith, Mackenzie, Gonzalez, Sonia, Lindsley, Craig W., Niswender, Colleen M., Gogliotti, Rocco G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9266622/ https://www.ncbi.nlm.nih.gov/pubmed/35671352 http://dx.doi.org/10.1021/acschemneuro.2c00113 |
Ejemplares similares
-
Clinical and Preclinical Evidence for M(1) Muscarinic Acetylcholine Receptor Potentiation as a Therapeutic Approach for Rett Syndrome
por: Smith, Mackenzie, et al.
Publicado: (2022) -
Profiling beneficial and potential adverse effects of MeCP2 overexpression in a hypomorphic Rett syndrome mouse model
por: Vermudez, Sheryl Anne D., et al.
Publicado: (2021) -
Discovery of (S)-2-Cyclopentyl-N-((1-isopropylpyrrolidin2-yl)-9-methyl-1-oxo-2,9-dihydro-1H-pyrrido[3,4-b]indole-4-carboxamide
(VU0453379): A Novel, CNS Penetrant Glucagon-Like Peptide 1 Receptor
(GLP-1R) Positive Allosteric Modulator (PAM)
por: Morris, Lindsey C., et al.
Publicado: (2014) -
Identification of Positive Allosteric Modulators VU0155094
(ML397) and VU0422288 (ML396) Reveals New Insights into the Biology
of Metabotropic Glutamate Receptor 7
por: Jalan-Sakrikar, Nidhi, et al.
Publicado: (2014) -
mGlu(5) Positive Allosteric Modulators Facilitate
Long-Term Potentiation via Disinhibition Mediated by mGlu(5)-Endocannabinoid Signaling
por: Xiang, Zixiu, et al.
Publicado: (2019)